Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Champions Oncology, Inc. (CSBR) since 2008 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Champions Oncology, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 771856.
Total stock buying since 2008: $13,577,773.
Total stock sales since 2008: $9,072,840.
Total stock option exercises since 2008: $3,837,393.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 15,444 | $95,971 | 0 | $0 | 105,137 | $395,840 |
| 2023 | 72,442 | $395,770 | 0 | $0 | 114,552 | $240,559 |
| 2022 | 0 | $0 | 0 | $0 | 43,333 | $139,097 |
| 2021 | 0 | $0 | 0 | $0 | 60,834 | $159,909 |
| 2020 | 1,321 | $7,758 | 739,673 | $5,307,368 | 344,922 | $1,786,687 |
| 2019 | 0 | $0 | 0 | $0 | 211,445 | $466,535 |
| 2018 | 25,235 | $167,544 | 35,868 | $560,790 | 100,000 | $210,000 |
| 2016 | 115,072 | $191,360 | 0 | $0 | 94,564 | $430,266 |
| 2015 | 18,671,052 | $5,000,000 | 0 | $0 | 0 | $0 |
| 2014 | 200,000 | $215,520 | 0 | $0 | 0 | $0 |
| 2013 | 15,000,000 | $7,500,000 | 0 | $0 | 0 | $0 |
| 2012 | 0 | $0 | 0 | $0 | 50,000 | $8,500 |
| 2011 | 0 | $0 | 5,100,000 | $2,913,000 | 0 | $0 |
| 2010 | 0 | $0 | 257,110 | $104,042 | 0 | $0 |
| 2009 | 0 | $0 | 389,062 | $187,640 | 0 | $0 |
| 2008 | 4,000 | $3,850 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2024-10 | 0 | $0 | 0 | $0 | 105,137 | $395,840 |
| 2024-01 | 15,444 | $95,971 | 0 | $0 | 0 | $0 |
| 2023-12 | 9,600 | $46,172 | 0 | $0 | 0 | $0 |
| 2023-10 | 17,130 | $109,655 | 0 | $0 | 114,552 | $240,559 |
| 2023-09 | 33,330 | $189,970 | 0 | $0 | 0 | $0 |
| 2023-03 | 12,382 | $49,973 | 0 | $0 | 0 | $0 |
| 2022-10 | 0 | $0 | 0 | $0 | 43,333 | $139,097 |
| 2021-10 | 0 | $0 | 0 | $0 | 26,667 | $42,400 |
| 2021-03 | 0 | $0 | 0 | $0 | 4,167 | $15,209 |
| 2021-01 | 0 | $0 | 0 | $0 | 30,000 | $102,300 |
| 2020-12 | 0 | $0 | 31,443 | $356,972 | 0 | $0 |
| 2020-10 | 0 | $0 | 0 | $0 | 26,667 | $145,601 |
| 2020-03 | 1,321 | $7,758 | 708,230 | $4,950,396 | 253,880 | $1,340,486 |
| 2020-02 | 0 | $0 | 0 | $0 | 64,375 | $300,600 |
| 2019-12 | 0 | $0 | 0 | $0 | 203,111 | $426,533 |
| 2019-01 | 0 | $0 | 0 | $0 | 8,334 | $40,002 |
| 2018-12 | 20,000 | $148,800 | 0 | $0 | 0 | $0 |
| 2018-11 | 0 | $0 | 5,000 | $68,750 | 0 | $0 |
| 2018-10 | 0 | $0 | 22,535 | $383,545 | 100,000 | $210,000 |
| 2018-09 | 0 | $0 | 8,333 | $108,495 | 0 | $0 |
| 2018-03 | 5,235 | $18,744 | 0 | $0 | 0 | $0 |
| 2016-10 | 107,039 | $178,242 | 0 | $0 | 0 | $0 |
| 2016-09 | 8,033 | $13,118 | 0 | $0 | 0 | $0 |
| 2016-07 | 0 | $0 | 0 | $0 | 94,564 | $430,266 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-10-31 | Ackerman Joel | Option Ex | 105,137 | 3.77 | 395,840 |
| 2024-01-12 | Mendelson Daniel Newman (Director) | Buy | 1,000 | 6.50 | 6,500 |
| 2024-01-11 | Mendelson Daniel Newman (Director) | Buy | 2,000 | 6.27 | 12,540 |
| 2024-01-10 | Mendelson Daniel Newman (Director) | Buy | 2,944 | 6.31 | 18,576 |
| 2024-01-09 | Mendelson Daniel Newman (Director) | Buy | 3,000 | 6.25 | 18,750 |
| 2024-01-08 | Mendelson Daniel Newman (Director) | Buy | 1,000 | 6.15 | 6,150 |
| 2024-01-05 | Mendelson Daniel Newman (Director) | Buy | 2,000 | 6.09 | 12,180 |
| 2024-01-04 | Mendelson Daniel Newman (Director) | Buy | 3,000 | 6.12 | 18,360 |
| 2024-01-03 | Mendelson Daniel Newman (Director) | Buy | 500 | 5.83 | 2,915 |
| 2023-12-21 | Mendelson Daniel Newman (Director) | Buy | 2,500 | 4.92 | 12,300 |
| 2023-12-20 | Mendelson Daniel Newman (Director) | Buy | 2,100 | 4.82 | 10,122 |
| 2023-12-19 | Mendelson Daniel Newman (Director) | Buy | 5,000 | 4.75 | 23,750 |
| 2023-10-17 | Ackerman Joel | Option Ex | 114,552 | 2.10 | 240,559 |
| 2023-10-11 | Mendelson Daniel Newman (Director) | Buy | 5,000 | 6.40 | 32,000 |
| 2023-10-10 | Mendelson Daniel Newman (Director) | Buy | 1,100 | 6.41 | 7,051 |
| 2023-10-06 | Mendelson Daniel Newman (Director) | Buy | 1,530 | 6.48 | 9,914 |
| 2023-10-05 | Mendelson Daniel Newman | Buy | 2,000 | 6.47 | 12,940 |
| 2023-10-04 | Mendelson Daniel Newman | Buy | 5,000 | 6.40 | 32,000 |
| 2023-10-03 | Mendelson Daniel Newman | Buy | 2,500 | 6.30 | 15,750 |
| 2023-09-29 | Mendelson Daniel Newman (Director) | Buy | 4,000 | 6.16 | 24,640 |
| 2023-09-28 | Mendelson Daniel Newman (Director) | Buy | 5,000 | 6.22 | 31,100 |
| 2023-09-27 | Mendelson Daniel Newman (Director) | Buy | 1,500 | 5.95 | 8,925 |
| 2023-09-26 | Mendelson Daniel Newman | Buy | 5,000 | 5.65 | 28,250 |
| 2023-09-22 | Mendelson Daniel Newman | Buy | 3,812 | 5.50 | 20,966 |
| 2023-09-21 | Mendelson Daniel Newman | Buy | 5,000 | 5.51 | 27,550 |
| 2023-09-20 | Mendelson Daniel Newman | Buy | 4,018 | 5.51 | 22,139 |
| 2023-09-19 | Mendelson Daniel Newman | Buy | 5,000 | 5.28 | 26,400 |
| 2023-03-17 | Morris Ronnie (CEO) | Buy | 12,382 | 4.04 | 49,973 |
| 2022-10-19 | Ackerman Joel | Option Ex | 16,667 | 3.21 | 53,501 |
| 2022-10-12 | Breitfeld Philip P. | Option Ex | 8,333 | 3.21 | 26,748 |
| 2022-10-12 | Sidransky David | Option Ex | 8,333 | 3.21 | 26,748 |
| 2022-10-12 | Tobin Scott R | Option Ex | 10,000 | 3.21 | 32,100 |
| 2021-10-15 | Sidransky David | Option Ex | 16,667 | 1.59 | 26,500 |
| 2021-10-12 | Tobin Scott R | Option Ex | 10,000 | 1.59 | 15,900 |
| 2021-03-23 | Breitfeld Philip P. | Option Ex | 4,167 | 3.65 | 15,209 |
| 2021-01-19 | Poliakoff Abba David | Option Ex | 30,000 | 3.41 | 102,300 |
| 2020-12-16 | Breitfeld Philip P. | Sale | 31,443 | 11.35 | 356,972 |
| 2020-10-30 | Tobin Scott R | Option Ex | 10,000 | 5.46 | 54,600 |
| 2020-10-16 | Sidransky David | Option Ex | 16,667 | 5.46 | 91,001 |
| 2020-03-26 | Mendelson Daniel Newman | Buy | 1,220 | 5.95 | 7,259 |
| 2020-03-24 | Morris Ronnie (CEO) | Sale | 75 | 5.25 | 393 |
| 2020-03-24 | Mendelson Daniel Newman | Buy | 26 | 5.50 | 143 |
| 2020-03-20 | Morris Ronnie (CEO) | Buy | 75 | 4.75 | 356 |
| 2020-03-11 | Morris Ronnie (CEO) | Option Ex | 126,940 | 5.28 | 670,243 |
| 2020-03-06 | Sandell Scott D (10% Owner) | Sale | 708,155 | 6.99 | 4,950,003 |
| 2020-03-03 | Ackerman Joel | Option Ex | 126,940 | 5.28 | 670,243 |
| 2020-02-18 | Mendelson Daniel Newman | Option Ex | 30,000 | 3.42 | 102,600 |
| 2020-02-11 | Mendelson Daniel Newman | Option Ex | 34,375 | 5.76 | 198,000 |
| 2019-12-02 | Ackerman Joel | Option Ex | 203,111 | 2.10 | 426,533 |
| 2019-01-16 | Morris Ronnie (CEO) | Option Ex | 4,167 | 4.80 | 20,001 |
| 2019-01-02 | Ackerman Joel | Option Ex | 4,167 | 4.80 | 20,001 |
| 2018-12-19 | Morris Ronnie (CEO) | Buy | 20,000 | 7.44 | 148,800 |
| 2018-11-06 | Mendelson Daniel Newman | Sale | 5,000 | 13.75 | 68,750 |
| 2018-10-12 | Ackerman Joel | Option Ex | 100,000 | 2.10 | 210,000 |
| 2018-10-01 | Ackerman Joel | Sale | 22,535 | 17.02 | 383,545 |
| 2018-09-20 | Mendelson Daniel Newman | Sale | 8,333 | 13.02 | 108,495 |
| 2018-03-27 | Morris Ronnie (CEO) | Buy | 2,300 | 3.62 | 8,319 |
| 2018-03-26 | Morris Ronnie (CEO) | Buy | 2,235 | 3.57 | 7,978 |
| 2018-03-23 | Morris Ronnie (CEO) | Buy | 440 | 3.50 | 1,540 |
| 2018-03-22 | Morris Ronnie (CEO) | Buy | 260 | 3.49 | 907 |
| 2016-10-21 | Morris Ronnie (President) | Buy | 30,000 | 1.66 | 49,890 |
| 2016-10-19 | Morris Ronnie (President) | Buy | 10,000 | 1.70 | 17,000 |
| 2016-10-18 | Ackerman Joel (Chief Executive Officer) | Buy | 2,000 | 1.70 | 3,390 |
| 2016-10-14 | Morris Ronnie (President) | Buy | 10,305 | 1.66 | 17,106 |
| 2016-10-14 | Ackerman Joel (Chief Executive Officer) | Buy | 1,300 | 1.65 | 2,150 |
| 2016-10-13 | Morris Ronnie (President) | Buy | 29,695 | 1.67 | 49,442 |
| 2016-10-13 | Ackerman Joel (Chief Executive Officer) | Buy | 6,000 | 1.68 | 10,062 |
| 2016-10-10 | Morris Ronnie (President) | Buy | 9,537 | 1.66 | 15,831 |
| 2016-10-07 | Ackerman Joel (Chief Executive Officer) | Buy | 5,000 | 1.64 | 8,200 |
| 2016-10-06 | Ackerman Joel (Chief Executive Officer) | Buy | 3,202 | 1.61 | 5,171 |
| 2016-09-23 | Ackerman Joel (Chief Executive Officer) | Buy | 33 | 1.65 | 54 |
| 2016-09-21 | Ackerman Joel (Chief Executive Officer) | Buy | 2,000 | 1.71 | 3,428 |
| 2016-09-20 | Morris Ronnie (President) | Buy | 3,000 | 1.58 | 4,740 |
| 2016-09-20 | Ackerman Joel (Chief Executive Officer) | Buy | 3,000 | 1.63 | 4,896 |
| 2016-07-21 | Morris Ronnie (President) | Option Ex | 94,564 | 4.55 | 430,266 |
| 2015-03-11 | Feldman Jesse (10% Owner) | Buy | 6,250,000 | .40 | 2,500,000 |
| 2015-03-11 | Agrawal Neeraj (10% Owner) | Buy | 6,250,000 | .40 | 2,500,000 |
| 2015-03-11 | Morris Ronnie (President) | Buy | 2,710,526 | .00 | 0 |
| 2015-03-11 | Mendelson Daniel Newman | Buy | 750,000 | .00 | 0 |
| 2015-03-11 | Ackerman Joel (Chief Executive Officer) | Buy | 2,710,526 | .00 | 0 |
| 2014-03-20 | Mendelson Daniel Newman | Buy | 97,500 | 1.08 | 105,300 |
| 2014-03-19 | Morris Ronnie (President) | Buy | 100,000 | 1.08 | 107,600 |
| 2014-03-19 | Mendelson Daniel Newman | Buy | 2,500 | 1.05 | 2,620 |
| 2013-01-28 | Agrawal Neeraj (10% Owner) | Buy | 7,000,000 | .50 | 3,500,000 |
| 2013-01-28 | Morris Ronnie (President) | Buy | 500,000 | .50 | 250,000 |
| 2013-01-28 | Brown Michael Maurice (10% Owner) | Buy | 7,000,000 | .50 | 3,500,000 |
| 2013-01-28 | Ackerman Joel (Chief Executive Officer) | Buy | 500,000 | .50 | 250,000 |
| 2012-01-09 | Poliakoff Abba David (Director) | Option Ex | 50,000 | .17 | 8,500 |
| 2011-06-21 | Martell James (Director) | Sale | 3,100,000 | .63 | 1,953,000 |
| 2011-04-05 | Martell James (Director) | Sale | 2,000,000 | .48 | 960,000 |
| 2010-09-07 | Martell James (Director) | Sale | 93,921 | .44 | 41,325 |
| 2010-05-11 | Martell James (Director) | Sale | 77,962 | .40 | 31,184 |
| 2010-02-26 | Martell James (Director) | Sale | 85,227 | .37 | 31,533 |
| 2009-08-13 | Martell James (Director) | Sale | 76,562 | .41 | 31,390 |
| 2009-05-21 | Martell James (Director) | Sale | 312,500 | .50 | 156,250 |
| 2008-10-03 | Burkett Douglas D (President) | Buy | 1,000 | .85 | 850 |
| 2008-09-30 | Burkett Douglas D (President) | Buy | 1,500 | 1.00 | 1,500 |
| 2008-09-24 | Burkett Douglas D (President) | Buy | 1,500 | 1.00 | 1,500 |
Insider trading activities including stock purchases, stock sales, and option exercises of CSBR listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Champions Oncology, Inc. (symbol CSBR, CIK number 771856) see the Securities and Exchange Commission (SEC) website.